$GTCB rEVO Biologics, Inc. Insider Trading
Get free email notifications about insider trading in rEVO Biologics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in rEVO Biologics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in rEVO Biologics, Inc. for free.
CIK Number: 0000904973
IRS Number: 043186494
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: GTCB
Company Address: 175 CROSSING BLVD FRAMINGHAM 01701
Former name: GTC BIOTHERAPEUTICS INC, date of change: 1993-05-17
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
rEVO Biologics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 01 2010 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 0.32 | 5,859 | 1,875 | 21,226 | 15.4 K to 21.2 K (+38.13 %) |
Oct 01 2010 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 0.32 | 4,688 | 1,500 | 16,797 | 12.1 K to 16.8 K (+38.72 %) |
Jul 06 2010 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 0.46 | 3,261 | 1,500 | 12,109 | 8.8 K to 12.1 K (+36.86 %) |
Jul 06 2010 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 0.46 | 2,174 | 1,000 | 8,494 | 6.3 K to 8.5 K (+34.40 %) |
Jul 06 2010 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 0.46 | 4,076 | 1,875 | 15,367 | 11.3 K to 15.4 K (+36.10 %) |
Jun 17 2010 | GTCB | rEVO Biologics, In ... | HEIDEN WILLIAM K | Chairman, President ... | Option Exercise | A | 0.42 | 300,000 | 126,000 | 300,000 | |
Apr 05 2010 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 0.55 | 3,409 | 1,875 | 11,291 | 7.9 K to 11.3 K (+43.25 %) |
Apr 05 2010 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 0.55 | 2,727 | 1,500 | 8,848 | 6.1 K to 8.8 K (+44.55 %) |
Apr 05 2010 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 0.55 | 1,818 | 1,000 | 6,320 | 4.5 K to 6.3 K (+40.38 %) |
Jan 08 2010 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Option Exercise | C | 2.24 | 6,750 | 15,098 | 0 | |
Jan 08 2010 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Option Exercise | C | 2.63 | 6,000 | 15,780 | 0 | |
Jan 08 2010 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Buy | C | 2.24 | 3,017,703 | 6,749,998 | 21,299,906 | 18.3 M to 21.3 M (+16.51 %) |
Jan 08 2010 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Buy | C | 2.63 | 2,281,368 | 5,999,998 | 18,282,203 | 16 M to 18.3 M (+14.26 %) |
Feb 12 2010 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Buy | P | 1.08 | 14,798 | 15,982 | 14,798 | 0 to 14.8 K |
Feb 12 2010 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Sell | S | 1.13 | 14,798 | 16,648 | 0 | 14.8 K to 0 (-100.00 %) |